Uzbekistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Uzbekistan Health News.

Press releases published on October 15, 2026

11 hours ago

Eindhovens medtechbedrijf Salvia BioElectronics start grootschalige studie in de VS met flinterdunne implantaten tegen migraine

Indeterminate GlobeNewswire

11 hours ago

R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026

Indeterminate GlobeNewswire

11 hours ago

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

Indeterminate GlobeNewswire

11 hours ago

Why Is Weight Loss Different During Menopause? Common Myths Debunked

Indeterminate GlobeNewswire

11 hours ago

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

11 hours ago

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026

Indeterminate GlobeNewswire

11 hours ago

Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

11 hours ago

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Indeterminate GlobeNewswire

11 hours ago

Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome

Indeterminate GlobeNewswire

11 hours ago

Rethink s’associe à Joe Fresh(MC) et à la Fondation Pharmaprix pour la santé des femmes(MC)

Indeterminate GlobeNewswire

11 hours ago

Rethink Partners with Joe Fresh™ & Shoppers Foundation for Women's Health™

Indeterminate GlobeNewswire

11 hours ago

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

Indeterminate GlobeNewswire

11 hours ago

Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026

Indeterminate GlobeNewswire

11 hours ago

Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027

Indeterminate GlobeNewswire

11 hours ago

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Indeterminate GlobeNewswire

11 hours ago

Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

Indeterminate GlobeNewswire

11 hours ago

Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire

11 hours ago

Profusa Receives ISO 13485:2016 Certificate from GMED

Indeterminate GlobeNewswire

12 hours ago

Affidea signs agreement to acquire two Alliance Medical centres in central London, accelerating its UK growth

Indeterminate GlobeNewswire

12 hours ago

Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire